Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH
The drugmaker named William Huyett as COO and Gina Consylman as SVP and CFO.
GCI Health has confirmed new hire Kath Kerry and maternity leave returner Rikki Jones as co-MDs of its London operation, the network's second hub alongside its New York headquarters.
DeVine will oversee the agency's health IT and medical device work.
Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds
Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.
Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial
FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs
Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head
W2O's Windy City office has added three health and analytics leaders over the past six months.
Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.
Optum vet Miller replaces Jessica Boden.
Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug
This year's offering includes access to the most current and in-depth data on salary and compensation trends, job satisfaction, recruitment and retention tactics, and more.
From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.
The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.
Every agency in the biz claims to have a "unique" culture and one that fuels a great deal of its success.
The successes of these pharma execs show that there's no one path to professional bliss.
Salaries are up — by a lot — and marketers are enthusiastic about their career prospects.
Now that Facebook, Apple, and Google have set their sights on healthcare, agencies find themselves under pressure from yet another flank.
Execs from JWT, J&J, and DanoneWeave react to the results of a new JWT/Geena Davis Institute study.
The CEO and founder of Antidote talks about what inspired him to start the company, which recently received funding from Merck.
The best marketers possess a mix of scientific know-how, digital dexterity, and unflappability. To keep them, agencies need to revise their thinking and tactics.
They are tasked with addressing an increasingly tough payer environment and ongoing criticism of the industry's drug-pricing practices.
A "seat at the table" isn't enough, says Oath's Allison Allen, in wide-ranging discussion at annual diversity conference.
Aaron Sklar, formerly of Welltok, replaces Christine Armstrong, who moved on to a Silicon Valley health startup.
Guidemark Health's Tina Fascetti offers Medela's Katie Busse advice on being a working mother in healthcare marketing.
The drugmaker tapped Mark Salyer, who previously managed Teva's respiratory business.
Incisive Health will next month welcome Francesca Scassellati Sforzolini as head of its Brussels office.
Novartis CEO Joe Jimenez to step down; Sanofi ends R&D plans for Zika vaccine; oncologists still struggle to predict metastasis